Tenet Healthcare (THC) Tops Q4 EPS by 15c, Offers Outlook

Tenet Healthcare (NYSE: THC) reported Q4 EPS of $1.40, $0.15 better than the analyst estimate of $1.25. Revenue for the quarter came in at $4.98 billion versus the consensus estimate of $4.87 billion.

GUIDANCE:

Tenet Healthcare sees Q1 2018 EPS of $0.73-$1.07, versus the consensus of $1.02. Tenet Healthcare sees Q1 2018 revenue of $1.79-18.3 billion, versus the consensus of $18.08 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Piper Sandler sees Google TPU sales hitting $104BN by 2028
• Source Agriventures files for Nasdaq IPO under ’SRAV’
• Jefferies Financial Group (JEF) Tops Q3 EPS by 8c